The latest craze is using "bath salts" to get high

March 2011

The latest craze is using "bath salts" to get high.

Poison control centers are now getting more calls about this in just one MONTH than in all of last YEAR combined.

These aren't really bath salts...they're actually new designer stimulants, such as 3,4-methylenedioxypyrovalerone (MDPV) or mephedrone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Testosterone More men will ask about testosterone replacement therapy
Cardiology whether hydrochlorothiazide should be used first-line for hypertension
Osteoporosis Many patients on chronic corticosteroids aren't getting the therapy they need to prevent osteoporosis and fractures
Antithrombotics whether dabigatran (Pradaxa) can be used instead of heparins (Lovenox, etc) for warfarin bridge therapy
Antithrombotics some patients might not benefit from Pradaxa (dabigatran) if it's stored improperly at home
Migraine adequate prophylaxis for migraines
Women's Health whether oral contraceptives are safe and effective in obese women
Interactions whether it's safe to combine a calcium channel blocker with a macrolide antibiotic
Pediatrics when to use antibiotics for acute otitis media in children
OTC Products requests to write prescriptions for OTC meds so they can be paid for with health savings accounts (HSAs)
Infectious Diseases methicillin-resistant Staph aureus (MRSA) infections in hospitalized patients
Substance Use Disorder The latest craze is using "bath salts" to get high
STIs new drug options and doses for treating sexually transmitted diseases (STDs) in CDC's new guidelines